SCHEMBL574692

SCHEMBL574692

CCCCN(CCCC)c1cc(C(=O)OC)cc(S(=O)(=O)N=CN(C)C)c1-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ ACLY P53396 7/20 0.38
▸ CNR2 P34972 3/20 0.36
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ ALOX5 P09917 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL574691 1.00 L3MBTL1 (0.40) L3MBTL1ACLYCNR2MEN1KMT2A
SCHEMBL574197 0.85 ALDH1A1 (0.40) L3MBTL1CNR2ALDH1A1KDM4ETSHR
SCHEMBL574196 0.85 ALDH1A1 (0.40) L3MBTL1CNR2ALDH1A1KDM4ETSHR
SCHEMBL10224228 0.84 LMNA (0.39) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL572944 0.84 LMNA (0.39) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL572943 0.84 LMNA (0.39) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL10224224 0.83 ALDH1A1 (0.39) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL572714 0.83 ALDH1A1 (0.39) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL572715 0.83 ALDH1A1 (0.39) L3MBTL1ALDH1A1KDM4ETSHRHPGD
SCHEMBL573814 0.82 LMNA (0.39) L3MBTL1ALDH1A1KDM4ECYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback